The type I insulin-like growth factor receptor (IGF-IR) is important for mitogenesis, transformation, and survival of tumor cells. The current study examines the effect of IGF-IR expression and activation on apoptosis in SHEP human neuroblastoma cells. SHEP cells undergo apoptosis which is prevented by IGF-I addition or overexpression of the IGF-IR (SHEP/IGF-IR cells). High mannitol treatment activates caspase-3 by 1 h in SHEP cells while caspase-3 activation is delayed by 3 h in SHEP/IGF-IR cells. Transfection with Bcl-2 (SHEP/Bcl-2 cells) prevents serum withdrawal and mannitol induced apoptosis and caspase-3 activation. Mannitol induces mitochondrial membrane depolarization in both SHEP and SHEP/IGF-IR cells. IGF-IR activation or overexpression of Bcl-2 in SHEP cells prevents mitochondrial membrane depolarization. Collectively, these results suggest that IGF-IR or Bcl-2 overexpression in neuroblastoma cells promotes cell survival by preventing mitochondrial membrane depolarization and caspase-3 activation, ultimately leading to increased tumor growth. Cell Death and Differentiation (2000) 7, 654 ± 665.
Introduction
Neuroblastoma is a sympathetic nervous system tumor derived from primordial neural crest cells and accounts for 8 ± 10% of all childhood solid tumors. 1 ± 4 Neuroblastoma can spontaneously regress, but progressive tumors remain untreatable by current chemotherapeutic and radiation therapy regimens. 1 The deletion of the short arm of chromosome 1 and N-myc amplification are the only two consistent genetic changes seen in neuroblastoma. 2 Growth factors, including the neurotrophins and the insulin-like growth factor (IGF) family, are likely involved in neuroblastoma progression and resistance to treatment. 2, 3, 5 The IGF-I family consists of two polypeptides, IGF-I and IGF-II, the type I and type II receptors (IGF-IR and IGF-IIR), and the IGF binding proteins. 6 The biological actions of IGF ligands are mediated through the IGF-IR and include mitogenesis, transformation, and protection from apoptosis. 7 Each of these actions are mediated by a different portion of the receptor, shown through mutational analyses, and likely requires different downstream targets to produce an effect. 8 ± 12 IGF-I, IGF-II, and the IGF-IR are expressed in a wide variety of tumor types, including neuroblastoma. 3 IGF-IR activation enhances neuroblastoma cell proliferation and survival, and increased IGF-IR expression increases the protection of neuroblastoma cells from apoptosis induced by chemotherapeutic agents and mannitol treatment. 13 Upon binding of IGF ligands to the IGF-IR, the IGF-IR is autophosphorylated and recruits the adaptor proteins IRS-1 and Shc.
14 These adaptor proteins then recruit further binding partners to activate two major downstream signaling pathways: the mitogen activated protein kinases (MAPKs) (which include the extracellular related kinases (ERKs), the jun kinases (JNKs) and p38) and the phosphatidyinositol-3 kinase (PI-3K) pathway. 15, 16 The predominant pathway involved in IGF-I mediated protection of cells from apoptosis is the PI-3K pathway. 17 ± 20 One of the principal downstream effectors of the PI-3K pathway which mediates cell survival is the serine/threonine kinase Akt. 21, 22 The IGF system can affect members of two families of apoptosis regulatory proteins, the Bcl-2 family and the caspases. 23, 24 The Bcl-2 family consists of many members, both pro-apoptotic and anti-apoptotic. 23 Bcl-2 and Bcl-X L are localized to the outer mitochondrial membrane and are thought to regulate channel pores in the mitochondrial membrane, controlling the release of factors which promote apoptosis such as apoptosis inducing factor (AIF) and cytochrome c. 25 ± 27 Bcl-2 and Bcl-X L expression are increased in several neuroblastoma cell lines and primary tumors 28, 29 resulting in increased survival and chemoresistance. IGF-IR activation can maintain Bcl-2 and Bcl-X L protein expression in high mannitol conditions which normally induce apoptosis in neuroblastoma cells. 30 The caspases are a family of cysteine proteases which preferentially cleave substrates at aspartate residues. There are currently 11 identified members of the caspase family 31 which can be loosely placed into one of two groups: the activator and the effector caspases. Caspases are activated when the holoenzyme is cleaved to release the prodomain from the active enzyme. 32 Blocking caspase activity in many cell types prevents apoptosis. 33 ± 35 The most downstream effector caspase, caspase-3, is essential for apoptosis to occur in many systems. 36, 37 IGF-IR activation can prevent the cleavage of caspase-3 and caspase-7 in both SH-SY5Y and SHEP neuroblastoma cells. Prevention of hyperosmotic-induced caspase activation by IGF-IR and subsequent protection from apoptosis occurs via the PI-3K in a Bcl-dependent mechanism. 13, 30, 38 The current study addresses the effects of IGF-IR activation and Bcl-2 expression on apoptotic events in SHEP human neuroblastoma cells. IGF-IR expression alone can delay mannitol-mediated caspase activation and prevent apoptosis induced by serum withdrawal in SHEP neuroblastoma cells. The cells are protected from mannitol induced apoptosis regardless of receptor number when IGF is present in the media, and caspase-3 is not cleaved. SHEP cells transfected with Bcl-2 are completely protected from both serum withdrawal and hyperosmotic induced apoptosis. Caspase-3 cleavage is also prevented by Bcl-2 overexpression.
Hyperosmotic stress also elicits mitochondrial changes in SHEP neuroblastoma cells. Changes in mitochondrial membrane depolarization are not seen at early time points, suggesting that caspase-3 activation occurs prior to this event in hyperosmotic-induced apoptosis. However, mannitol causes dose dependent mitochondrial membrane depolarization in SHEP and SHEP/IGF-IR cells at a later time point, and this depolarization is prevented by the addition of IGF-I. SHEP/Bcl-2 cells show no mitochondrial membrane depolarization in the presence of high doses of mannitol. These results suggest that IGF-I promotes neuroblastoma tumorigenesis in part by blocking mitochondrial membrane depolarization and protecting cells from apoptosis through caspase-3 and Bcl-2 dependent mechanisms.
Results

IGF-I prevents apoptosis in SHEP neuroblastoma cells
The SHEP human neuroblastoma cell line was subcloned from SK-N-SH. SHEP cells have little IGF-IR, 13 ,40 cannot form colonies in soft agar or tumors in nude mice, and requires serum for growth. 41 First, the effect of IGF-I on apoptosis was examined in SHEP cells under hyperosmotic conditions. Cells were exposed to increasing concentrations of mannitol with or without IGF-I. Even in the absence of mannitol, over 30% of the cells are apoptotic after 24 h, suggesting that serum withdrawal alone induces apoptosis in SHEP cells. The number of apoptotic cells increases to over 60% in 300 mM mannitol (Figure 1 ), indicating significant additional apoptosis does not occur until the media is very hyperosmotic. Upon addition of 10 nM IGF-I to the media, more than 50% of the cells are rescued from both serum-withdrawal and hyperosmotic-induced apoptosis ( Figure 1 ). All conditions in which IGF-I was added are statistically significant from the corresponding experimental condition lacking IGF-I. Although SHEP cells do express low levels of the IGF-IR, the receptors present are functional. 40 Considering the low amount of IGF-IR expression in normal SHEP cells, this implies that very little IGF-IR is necessary for protection of neuroblastoma cells from apoptosis.
To further demonstrate the ability of IGF-I to rescue SHEP cells from apoptosis, bisbenzimide staining was performed. SHEP cells in isotonic media (DMEM alone) display few pyknotic nuclei. Although DNA fragmentation is detected by flow cytometry at 24 h in cells in DMEM alone, morphological changes in the nuclei of these cells as examined by light microscopy are not seen. When cells are exposed to 300 mM mannitol, there is a decrease in overall cell density and many fragmented nuclei are seen, indicative of cells which had already completed the apoptotic process (Figure 2a) . However, IGF-I addition to the media prevents morphological changes associated with apoptosis and prevents the loss in cell density seen in hyperosmotic conditions (Figure 2b ).
Caspase-3 is the most downstream caspase and caspase cleavage is necessary for apoptosis to occur in many systems. 36, 37 Upon activation, caspase-3 is cleaved from the 32 kD proenzyme into 17 and 14 kD fragments. Therefore, caspase-3 cleavage was investigated in SHEP cells as another measure of apoptosis. Cells were exposed to 300 mM mannitol for 1 to 12 h. Western blot analysis shows the presence of the 17 and 14 kD activation bands after 1 h of hyperosmotic exposure (Figure 3a) , which continues through 12 h. SHEP cells were then exposed to IGF-IR overexpression prevents apoptosis induced by serum withdrawal and delays caspase-3 activation SHEP cells were previously transfected with varying levels of IGF-IR to determine the effect of IGF-IR expression on mitogenesis and resistance to cell death. 13 When SHEP cells are transfected with the IGF-IR, serum withdrawal alone does not induce apoptosis. In DMEM alone, about 35% of normal untransfected SHEP cells are apoptotic ( Figure 1 ). In contrast, only 10% of SHEP/IGF-IR cells are apoptotic in serum-free media (Figure 4a ). The number of apoptotic SHEP/IGF-IR cells increases with increasing hyperosmolar conditions, with over 75% of the cells apoptotic at 300 mM mannitol. IGF-I rescues a little over 50% of the cells at each concentration (Figure 4a ), which is statistically significant for all mannitol concentrations tested. These data show that transfection of the IGF-IR alone protects SHEP cells from serum withdrawal induced apoptosis.
We then investigated activation of two of the principal pathways downstream from the IGF-IR, Akt and MAP kinase, in the SHEP and SHEP/IGF-IR cells (Figure 4b ). In untransfected SHEP cells, Akt and Erk1/Erk2 were phosphorylated upon stimulation with IGF-I for 30 min, once again confirming the activation of the IGF-IR in SHEP cells, despite the low number of receptors present. In SHEP/IGF-IR cells however, both signaling proteins were phosphorylated to a greater extent upon stimulation with IGF-I than were the parental SHEP cells, as is expected with increased expression of the IGF-IR. Interestingly, in SHEP/IGF-IR cells, Akt and Erk1/Erk2 were also phosphorylated in the absence of IGF-I, indicating autophosphorylation without ligand. Therefore, IGF-IR overexpression likely protects SHEP cells from serum withdrawal induced apoptosis through a low basal activation of the IGF-IR and downstream signaling cascades in the absence of ligand stimulation.
Caspase-3 activation was examined in whole cell lysates collected from SHEP/IGF-IR cells exposed to hyperosmotic conditions for time periods from 1 to 12 h. In normal SHEP cells, caspase-3 activation is detected using Western blot analysis by 1 h post-mannitol exposure (Figure 3a ). Given the effect of IGF-IR overexpression on caspase-3 activation in SHEP cells, we next examined the effect of blocking caspase-3 activation using an effector caspase inhibitor, bok-asp-fmk, on hyperosmotic induced apoptosis in these cells (Figure 5c ). Upon exposure of SHEP/IGF-IR cells to 300 mM mannitol for 24 h, 50% of the cells became apoptotic as previously reported. In the presence of IGF-I, only 16% of SHEP/IGF-IR cells were apoptotic in high mannitol conditions. When SHEP/IGF-IR cells are incubated with bok-asp-fmk, 26% of the cells become apoptotic in hyperosmotic media. In the presence of both IGF-I and bok-asp-fmk, only 8.7% of SHEP/IGF-IR cells undergo hyperosmotic-induced apoptosis. Together, these data suggest that although IGF-I primarily prevents apoptosis in a caspase-3 mediated process, IGF-I may also prevent a portion of the cells from undergoing apoptosis in a noncaspase mediated manner.
SHEP cells transfected with the IGF-IR in the reverse orientation (FC-4 cells), which would prevent the formation of endogenous functional IGF-IR protein, 13 not only showed control levels of apoptosis at low concentrations of mannitol, but also increased sensitivity to a hyperosmotic environment at higher mannitol concentrations ( Figure 6 ). At higher mannitol concentrations, 45 ± 60% of SHEP cells were apoptotic and 75 ± 85% of FC-4 cells were apoptotic. In the presence of IGF-I, more FC-4 cells were apoptotic compared to SHEP/IGF-IR cells ( Figure 1 ) at all mannitol concentrations tested ( Figure 6 ). In untransfected SHEP cells and SHEP/IGF-IR cells, over 50% of the cells are rescued by IGF-I. In the FC-4 cells however, IGF-I only rescues about 25% of the cells in high mannitol conditions, and IGF-I does not protect the cells in low mannitol conditions. This implies that transfection of IGF-IR in the reverse orientation is preventing endogenous IGF-IR from exerting a protective effect.
Bcl-2 overexpression prevents apoptosis in SHEP neuroblastoma cells IGF-IR activation can regulate the expression of Bcl-2 in SH-SY5Y neuroblastoma cells, suggesting that IGF-I neuroprotection is mediated in part by the Bcl-2 family of proteins. 30 To support a role for Bcl-2 in preventing apoptosis in neuroblastoma, SHEP cells, which normally do not express Bcl-2, 28, 39 were stably transfected with this protein. 39 As shown previously, when normal SHEP cells are exposed to hyperosmotic media, about 60% of the cells undergo apoptosis as measured by flow cytometry of propidium iodide stained cells. Approximately half of these cells are rescued by the addition of IGF-I to the media (Figure 1 ). In contrast, SHEP/Bcl-2 cells show only 2 ± 4% apoptotic cells in response to hyperosmotic media with or without IGF-I addition after 24 h (Figure 7a ). This demonstrates a profound effect of Bcl-2 in protecting these cells against an apoptotic stimulus.
To further support this finding, lysates from SHEP/Bcl-2 cells were collected 1 ± 4 days after hyperosmotic exposure and examined for caspase-3 cleavage. Little caspase-3 cleavage is detected, even after 4 days of exposure to hyperosmotic conditions (Figure 7b ). Because SHEP cells are normally serum dependent, 40 therefore we would expect substantial apoptosis in SHEP cells maintained in DMEM alone after a period of 4 days. However, no caspase-3 cleavage is detected (Figure 7b) , and no detached cells are seen, suggesting viable cells in serumfree conditions over this period of time. 
IGF-I prevents mitochondrial membrane depolarization in SHEP and SHEP/IGF-IR cells
Bcl-2 exerts its effects primarily at the endoplasmic reticulum and the mitochondria. 42 Events occurring at the mitochondria have a profound effect on apoptosis in many cell types. 26, 43, 44 Because Bcl-2 overexpression prevented hyperosmoticinduced apoptosis and caspase-3 cleavage in SHEP cells, we reasoned that changes in the mitochondrial membrane potential may serve as an early marker of neuroblastoma apoptosis. Depolarization of the mitochondrial membrane was measured using Rh123 in SHEP and SHEP/IGF-IR cells at 1, 3, and 6 h, time points coincident with caspase-3 activation in these cells. In DMEM alone and DMEM+10 nM IGF-I, the mitochondrial membrane potential is essentially the same in both cell types at all time points tested (data not shown). In hyperosmotic conditions, untransfected SHEP cells show a slight increase in the number of cells with a depolarized membrane by 6 h, but this increase is not statistically significant when compared to cells maintained in DMEM alone (Figure 8a ). Therefore, a later time point, 18 h, was were treated with increasing concentrations of mannitol with or without IGF-I followed by incubation with Rh123 to examine mitochondrial membrane potential. In both cell lines at 18 h, the number of cells with depolarized mitochondria increases in mannitol conditions, and this mitochondrial membrane depolarization is prevented by IGF-I. In SHEP/IGF-IR cells exposed to IGF-I, the number of cells with increased Rh123 fluorescence is even less than control, implying increased protection over that seen in SHEP cells (Figure 8c) . SHEP/Bcl-2 cells were also examined for the response of the mitochondria to hyperosmotic exposure. SHEP/Bcl-2 cells were exposed to 300 mM mannitol+10 nM IGF-I for the same early time points examined above (1, 3 and 6 h).
Virtually no change in Rh123 fluorescence was detected, suggesting no change in the mitochondrial membrane potential (Figure 9a ). When SHEP/Bcl-2 cells were exposed to increasing concentrations of mannitol at the later 18 h time point, less than 5% of the viable cells showed mitochondrial membrane depolarization (Figure  9b) , indicating a complete protection of the mitochondria from hyperosmotic-induced mitochondrial membrane depolarization. Taken together, these data suggest that IGF-I acts upstream from the mitochondria and may exert its protective effect in part by preventing mitochondrial membrane depolarization, either directly or indirectly, through a Bcl protein-dependent mechanism.
Discussion
The IGF family plays a role in tumorigenesis. The IGFs and the IGF-IR are expressed in many primary tumors 45 and tumor cell lines. 46 IGF signaling though the IGF-IR is important for protecting tumor cells from apoptosis.
13,47 ± 49 Antibodies against IGF-IR, antisense strategies against IGF-I and IGF-IR, and dominant negative IGF-IR mutants all reduce cell survival and promote cell death. 50 ± 52 Conversely, overexpression of IGF-IR enhances cell survival in response to death signals 13, 53, 54 and IGF-I, via interaction with IGF-IR, can prevent apoptosis. 55 ± 57 IGFs can also alter the drug sensitivity of cancer cells, rendering them resistant to chemotherapy induced apoptosis. 58 ± 60 In the current study, we examined the role the IGF system plays in neuroblastoma, a pediatric tumor of the peripheral nervous system. We have previously shown that hyperosmotic exposure induces apoptosis in SHEP neuroblastoma cells. 13 In this study, we found a significant portion of SHEP cells become apoptotic after serum withdrawal, and the number of apoptotic cells only increases after high doses of mannitol. Serum withdrawal induces apoptosis in many neuronal cell types. In cerebellar granule cells, serum withdrawal potentiates apoptosis induced by potassium withdrawal, with less than 50% viable cells after 30 h. 61 Serum and potassium deprivation also increase caspase-3 activity and caspase-3 mRNA levels in cerebellar granule cells. 62 Removal of serum induces apoptosis in hippocampal neuron populations as well within 6 h. 63 Several neuroblastoma cell lines undergo apoptosis upon serum-withdrawal, including NG108 cells, 64 NB 2a cells, 65 and SK-N-BE cells. 66 IGF-I rescues several cell types from serum withdrawal induced apoptosis, including HBL100 human breast cancer cells, 58 H9C2 cardiac muscle cells, 67 differentiated PC-12 cells, 68 and dorsal root ganglion neurons. 69 In SHEP cells, IGF-I rescued over 50% of the cells from apoptosis in all conditions, despite the low levels of IGF-IR present in SHEP cells. 13 Although SHEP cells have little IGF-IR, the IGF-IR present is functional and activates downstream signaling pathways [ 40 , Figure 4b , this study]. These downstream signaling cascades can then protect the cells from hyperosmotic-induced apoptosis despite low receptor numbers.
IGF-I appears to act upstream from the caspases. In SHEP cells, caspase-3 activation occurs within 1 h of mannitol exposure, and caspase-3 activation was prevented by IGF-I addition. Caspase-3 activation occurs in response to drug treatment in several neuroblastoma cell lines. SH-SY5Y cells, which were subcloned from the same parental line as the SHEP cells used in this study, show caspase-3 cleavage in response to staurosporine by 3 h, 70 and by 6 h in response to mannitol treatment. 38 In SH-SY5Y cells, caspase-3 activation also occurs in response to nitric oxide, 71 hypoxia/hypoglycemia, or excitotoxin exposure. 72 The IGF-IR is postulated to play a role in the progression of several tumor types. 73 IGF-IR is overexpressed in most breast cancer cell lines, and IGF-IR autophosphorylation and tyrosine kinase activity correlate with breast malignancy. 74 Inhibition of IGF-IR expression causes neuroblastoma tumor regression in mice, and this regression is through the induction of apoptosis. 75 We have previously shown that transfection of SHEP cells with the IGF-IR transforms the cells and decreases their susceptibility to apoptosis induced by mannitol or etoposide treatment. 13 In the current study, IGF-IR overexpression prevents apoptosis induced by serum withdrawal and delays caspase-3 activation. In support of our findings, overexpression of the IGF-IR enhances survival of Rat-I fibroblasts exposed to dimethylformamide 76 and myocytes after infarction. 77 In addition, mutational analysis shows distinct regions of the IGF-IR mediate mitogenesis, transformation, and cell survival. 10 ± 12 Since about 50% of SHEP and SHEP/IGF-IR cells are rescued in high mannitol conditions in response to IGF-I, the protection of SHEP/IGF-IR cells from serum withdrawal induced apoptosis may be due to the transformation of these cells by IGF-IR transfection rather than by increased IGF-I sensitivity.
In SHEP/IGF-IR cells, phosphorylation of two downstream signaling molecules, Akt and Erk1/Erk2, was increased over that seen in SHEP parental cells upon exposure to IGF-I ligand. This result was expected given the high expression of the IGF-IR. 13 In parallel Akt and Erk1/Erk2 were also phosphorylated in the absence of IGF-I ligand. This likely explains how overexpression of the IGF-IR protects SHEP neuroblastoma cells from serum withdrawal induced apoptosis without IGF-I ligand present. The IGF-IR is potentially autophosphorylated when overexpressed, producing autoactivation, leading to activation of downstream signaling molecules mediating cell survival. In human breast cancer, cells taken from malignant tumors as opposed to normal cells showed IGF-IR phosphorylation and kinase activity 2 ± 3-fold higher than control cells in the absence of IGF ligand. 74 In MCF-7 breast cancer cells, overexpression of the IGF-IR increased cell-cell adhesion and the formation of aggregates as well, which in and of itself enhances proliferation and cell survival, even though sensitivity to IGF-I ligand was not enhanced. 78 Therefore, these two studies, in addition to our own, suggest the possibility that tumor cells with increased IGF-IR expression may be protected from apoptosis induction through either autophosphorylation of the receptor or upregulation of other protective proteins, leading to tumor cell survival in the absence of growth factors.
Bcl-2 is an anti-apoptotic protein found in both tumor 79 and normal cell populations, such as neurons. 80 We have previously reported that mannitol treatment decreases Bcl-2 protein expression in SH-SY5Y neuroblastoma cells. 30 We therefore compared the ability of hyperosmotic stress to induce apoptosis in SHEP cells, which do not express Bcl-2, and SHEP cells overexpressing Bcl-2 (SHEP/Bcl-2). Bcl-2 overexpression completely blocked caspase-3 activation and apoptosis induced by serum withdrawal or hyperosmotic stress. Similar findings are reported in GT1-7 neuronal cells where serum withdrawal and drug induced apoptosis is prevented by Bcl-2, which normally acts upstream from the caspases. 81 A rat colon carcinoma cell line, which normally yields regressive tumors, is also protected from serum withdrawal induced apoptosis by Bcl-2 transfection. 82 These Bcl-2 overexpressing clones produced metastatic, lethal tumors. 82 Finally, in SHEP neuroblastoma cells, Bcl-2 overexpression prevents apoptosis induced by cisplatin or etoposide. 39 The exact role for Bcl-2 in protecting against apoptosis is under investigation. Bcl-X L , a protein highly homologous to Bcl-2, is thought to regulate a channel pore in the outer mitochondrial membrane through which apoptosis inducing factors, such as AIF or cytochrome c, are released into the cytoplasm to activate the caspase cascade. 42 This hypothesis is based on the similarity of the threedimensional structure of Bcl-X L to pore-forming domains of bacterial toxins, such as diphtheria toxin and poreforming colicins, and the ability of overexpression of Bcl-X L to effect the release of cytochrome c into the cytoplasm. 42 Bcl-X L can also form a channel when it is inserted into synthetic lipid membranes. 27 A similar role has been postulated for a Bcl-2 channel. 25, 83, 84 Bcl-2 can bind to the permeability transition pore complex, thereby preventing permeability transition and subsequent mitochondrial membrane depolarization. 43, 44 Given the role of Bcl-2 and mitochondrial events in apoptosis, we investigated the effect of IGF-I, IGF-IR, and Bcl-2 expression on mitochondrial membrane depolarization in SHEP cells. Early time points were chosen first since the predominant hypothesis regarding the mitochondria and effector caspase activation places mitochondrial membrane depolarization and cytochrome c release before downstream caspase activation. However, essentially no changes in mitochondrial membrane potential were detected in SHEP cells by 6 h of mannitol exposure. These data suggest that in hyperosmotic-induced apoptosis in SHEP cells, caspase-3 activation occurs first in a mitochondria-independent mechanism. Mannitol induces mitochondrial membrane depolarization in SHEP cells in about 45% of the cells at 18 h, and this depolarization is blocked by the addition of IGF-I to the media or by Bcl-2 overexpression. IGF-IR transfection of SHEP cells had little effect on mitochondrial membrane potential changes in this experimental paradigm.
Mitochondrial membrane potential is affected by Fas induction in Jurkat cells, by IL-3 withdrawal in FL5.12 cells, 26 and by doxorubicin and betulinic acid in SHEP neuroblastoma cells. 85 In each of these cases, Bcl-2 or Bcl-X L prevent mitochondrial membrane depolarization; how-ever, in these systems, disruption of mitochondrial membrane potential precedes caspase-3 activation. In contrast, caspase-3 activation occurs prior to mitochondrial membrane depolarization in staurosporine treated Jurkat cells; in this experimental paradigm, cytochrome c release and caspase-3 activation occur concomitantly and prior to mitochondrial membrane potential loss. 86 UVB irradiation or staurosporine treatment of HeLa cells also caused cytochrome c translocation to the cytosol followed by caspase-3 activation, and inhibition of caspases by zVAD.fmk prevented mitochondrial membrane depolarization but not cytochrome c translocation. 87 Staurosporine treatment induces cytochrome c release by 1 h and caspase-3 activation by 2 h in SH-SY5Y neuroblastoma cells, and both of these events occur even in the presence of the mitochondrial permeability transition inhibitors bongkrekic acid and cyclosporin A. 88 When SH-SY5Y neuroblastoma cells are treated with caspase-3 inhibitors, the mitochondrial membrane potential is maintained in the presence of high glucose, a stimulus which normally causes mitochondrial membrane depolarization (James Russell, personal communication). This suggests that mitochondrial membrane depolarization lies downstream from effector caspase activation in glucose-mediated death of neuroblastoma cells as well.
Although the mechanism of early cytochrome c release is unknown, recent reports show that Bax translocation to the mitochondria can induce cytochrome c translocation to the cytosol in HeLa cells and SH-SY5Y cells. 88, 89 Bax can induce cytochrome c release from isolated mitochondria within 30 min without mitochondrial permeability transition. 89, 90 In cell free systems, cytochrome c is released spontaneously and leads to caspase-3 cleavage without a loss of mitochondrial membrane potential. 91 Taken together, these studies suggest that cytochrome c can be released without mitochondrial permeability transition, potentially through a Bax-dependent mechanism. Cytochrome c can then activate caspase-3 within the time frame seen in this study. Active caspase-3 can also accelerate cytochrome c release in a cell free system. 92 Therefore, caspase-3 could then feed back to the mitochondria, eventually causing mitochondrial permeability transition which finally leads to a loss of mitochondrial membrane potential. Further studies will address the validity of this potential mechanism in hyperosmotic-induced apoptosis in neuroblastoma cells.
In summary, IGF-I regulation of apoptosis in SHEP cells exposed to high concentrations of mannitol could occur in several ways. IGF-I clearly prevents both caspase-3 activation and mitochondrial membrane depolarization in this system. These could be two independent events, or could act in concert as the prevention of caspase-3 cleavage by IGF-I could then block the depolarization of the mitochondrial membrane. IGF-I could also prevent the translocation of Bax to the mitochondria or cytochrome c to the cytosol, which could prevent both caspase-3 cleavage and mitochondrial membrane depolarization. Short term activation of the IGF-IR could lead to protection of neuroblastoma cells by the PI-3 kinase-Akt phosphorylation of Bad as described in other cell systems, 93, 94 or as an uncharacterized Akt-independent pathway. A more long term effect of IGF-IR activation could be to stabilize or increase Bcl-2 protein expression, preventing a`leaky' mitochondrial membrane thus allowing Bcl-2 to exert its protective effect under apoptosis-inducing conditions. Finally, IGF-IR activation could allow for increased cell adhesion and the formation of aggregates, which can decrease the susceptibility of neuroblastoma cells to apoptosis. Further studies examining the effects of IGF-IR on apoptosis will help elucidate the role of the IGF-IR in neuroblastoma progression and survival. 
Materials and Methods
Materials
Cell culture
SHEP human neuroblastoma cells were grown in DMEM+10% CS at 378C in a humidified atmosphere with 10% CO 2 . SHEP cells transfected with IGF-IR (SHEP/IGF-IR), 13 SHEP cells transfected with bcl-2 (SHEP/Bcl-2), 39 and SHEP cells transfected with the full length IGF-IR in the reverse orientation 13 were maintained in DMEM+10% CS+250 mg/ml G418 (Gibco BRL). All cell types were routinely subcultured by removing cells from the plates with trypsin-EDTA.
Transfection of SHEP cells
SHEP neuroblastoma cells were stably transfected with pSFFVneo/ rhIGF-IR (SHEP/IGF-IR cells), 13 pSFFVneo/Bcl-2 (SHEP/Bcl-2 cells), 39 or pSFFVneo with the full length IGF-IR in the reverse orientation 13 (FC-4 cells) using Lipofectin (Life Technologies, Inc., Gaithersburg, MD, USA) following manufacturer's instructions. Transfected cells were selected using 500 mg/ml G418.
Flow cytometry
Analysis of DNA content was performed using flow cytometry. Cells were plated in 6-well plates at 1610 5 cells/cm 2 . After reaching near confluency, cells were serum deprived for 4 h and exposed to experimental conditions for the indicated times. Cells were removed from the plates with trypsin-EDTA, rinsed in HBSS, fixed in ice cold 70% ethanol, and stored at 48C. Cells were stained 2 ± 12 h with 18 mg/ml propidium iodide and 40 mg/ml RNase A at 48C. DNA content of propidium iodide stained cells was measured and separated into phases of the cell cycle based on the propidium iodide fluorescence.
Per cent apoptotic cells in all cases was taken as per cent sub-g 0 DNA as measured on an Epics Elite flow cytometry system (Coulter Cytometry, Hialeah, FL, USA). All results are expressed as the mean per cent apoptotic cells of three experiments+the standard error of the mean (S.E.M.).
Western immunoblotting
Western blot analyses were performed as previously described. 40 Briefly, cell lysates were collected using RIPA buffer (20 mM Tris [pH 7.4], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.1% SDS, 1% sodium deoxycholate, 1% Triton X-100, 1 mM sodium orthovanadate, 0.1 trypsin inhibitor units/ml, 10 mg/ml leupeptin, and 100 mg/ml PMSF). Seventy mg of protein were loaded and run on a 12.5% SDS ± PAGE gel. After transfer to nitrocellulose membranes, the membranes were incubated with anti-caspase-3 antibody (Pharmingen, 1 : 1000) for 2 h, anti-phospho-Akt (New England Biolabs, 1 : 1000) overnight, or antiphospho-Erk1/Erk2 antibody (New England Biolabs, 1 : 1000) overnight. All membranes were further incubated with horseradish peroxidase conjugated anti-rabbit secondary antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA; 1 : 2000 dilution) for 1 h, developed with ECL (Amersham), and exposed to film (Hyperfilm-ECL, Amersham). Blots shown are one of three independent experiments performed.
Bisbenzimide staining
Cells were plated at 1610 4 cells/cm 2 on glass coverslips and grown in DMEM+10% CS. Serum deprived cells were treated for 24 h, fixed in 4% paraformaldehyde for 15 min, rinsed in phosphate buffered saline (PBS), stained with 1 mg/ml bisbenzimide in PBS for 30 min, then rinsed in PBS and mounted onto slides. Cells were viewed under ultraviolet illumination on a Leitz Orthoplan microscope.
Caspase-3¯uorometric activity assay
Near confluent cells were serum deprived for 4 h, treated with 300 mM mannitol, and harvested at the indicated times using trypsin-EDTA. The caspase-3 fluorometric activity assay was performed per instructions (Pharmingen, San Diego, CA, USA). Briefly, suspended cells were rinsed in PBS. Twenty mg of the DEVD-AMC substrate was added, and cells were incubated at 378C for 1 h. When caspase-3 is activated, it cleaves the DEVD-AMC artificial substrate, causing an increase in fluorescence. The fluorescence was immediately analyzed by flow cytometry. Results are expressed as the change in fluorescence from control. Results are the mean+S.E.M. for three experiments performed.
Measure of mitochondrial membrane potential
Cells were treated for flow cytometry as described above. After 18 h of treatment, cells were exposed to 5 mg/ml Rhodamine 123 (Rh123), a mitochondrial specific dye, in HBSS for 30 min at 378C. Cells were then lifted from the plate with trypsin-EDTA, stained with propidium iodide as described above, and immediately analyzed by flow cytometry. Cells with a depolarized mitochondrial membrane have decreased Rh123 fluorescence. 26 Results are expressed as per cent propidium iodide, excluding cells with Rh123 fluorescence below control levels. Results are the mean+S.E.M. for three independent experiments.
